Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

MSBase Study Group

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences